X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Clinical Trials News - 21/Jun 03:06

Palatin Announces the Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered with a PDE5i for the Treatment of Erectile Dysfunction

CRANBURY, N.J., June 20, 2024. Palatin Technologies, Inc., a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, announced the initiation of a Phase 2...

Articles similaires

Sorry! Image not available at this time

Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients

drugs.com - 29/Jun 22:06

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 28, 2024 Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or...

Sorry! Image not available at this time

OPINIONISTA: Changing frontiers of wastewater treatment — ignore nature, or embrace nature-based solutions?

daily maverick - 26/Jun 18:33

The human species is currently at an inflexion point. Can we mobilise the quantum of ingenuity needed to expand and advance our current capacity to...

Sorry! Image not available at this time

OPINIONISTA: Changing frontiers of wastewater treatment — ignore nature, or embrace nature-based solutions?

daily maverick - 26/Jun 18:33

The human species is currently at an inflexion point. Can we mobilise the quantum of ingenuity needed to expand and advance our current capacity to...

Sorry! Image not available at this time

University of Nebraska Medical Center enrolls patient for RenovoRx's pivotal phase III TIGeR─PaC trial

pharmabiz.com - 28/Jun 00:00

RenovoRx, Inc, a clinical─stage biopharmaceutical company developing novel precision oncology therapies based on a local drug─delivery platform,...

Sorry! Image not available at this time

PTC Therapeutics announces interim results from phase 2 PIVOT─HD study of PTC518 in Huntington's disease patients

pharmabiz.com - 22/Jun 00:00

PTC Therapeutics, Inc, a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated...

Sorry! Image not available at this time

First Patient Dosed in the MAD Part 2 Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

drugs.com - 26/Jun 19:06

CAMBRIDGE, Mass., June 26, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic...

Sorry! Image not available at this time

Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism

mangaloremirror.com - 02/Jul 12:51

MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing...

Sorry! Image not available at this time

KalVista initiates KONFIDENT-KID trial for on-demand treatment of HAE attacks with sebetralstat in children aged 2 to 11

haei.org - 27/Jun 06:40

KalVista initiates KONFIDENT-KID trial for on-demand treatment of hereditary angioedema attacks with sebetralstat in children aged 2 to 11 KalVista...

Sorry! Image not available at this time

World Health Organization issues warning on falsified medicines used for diabetes treatment and weight loss

pharmabiz.com - 22/Jun 00:00

The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are used for treatment of...

Sorry! Image not available at this time

WHO issues warning on falsified medicines used for diabetes treatment and weight loss

caribbeannewsglobal.com - 23/Jun 05:59

GENEVA, Switzerland – The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are...